Introducing Sequoia Clinical Research: A Letter from CEO Dan White

Bringing together JCCT, Juno Research, and CRC

Three organizations, one name, more possibilities

As you may have already heard, Johnson County ClinTrials (JCCT), Juno Research, and CRC have joined together to become Sequoia Clinical Research. I’m excited to share why we made that decision and what we’re looking forward to accomplishing under one unified banner.

Over the past year and a half, our three teams have been learning to work as one. The rebrand gave us a chance to step back and ask what matters most, starting with our “why.” The answer became our tagline, “Connecting People to Advance Research.”

Our new name was inspired by nature. Sequoias are the world’s largest trees despite having relatively shallow roots. They stand in part because their roots spread outward and intertwine with their neighbors’. Each of our sites is like one of those trees, and our shared mission is the root system that connects us.

For sponsors, that means multiple sites, one contact and one contract, with a team focused on helping them meet their recruitment goals.

For our patients and staff, we’re the same company with a new name, but with even greater potential for impact.

The end result is more possibilities and better results for stakeholders.

More expertise and more possibilities

Every site has a clear clinical focus. Whether it’s vaccine research know-how at JCCT in Lenexa, endocrinology expertise at Juno Research in Houston, or nephrology specialty at CRC in Kansas City, each offers something different.

Sponsors get therapeutic depth in one network, with physicians who have study track records in their respective fields. And that expertise compounds across the network, as sites share knowledge, resources and best practices to strengthen what each can deliver.

Patients keep the physicians they trust. Our teams preserve the culture they built. Together, we are all a better version of ourselves.

Better performance together for both patients and sponsors

Like intertwined roots, expertise and capabilities extend across the network. By sharing specialized expertise and centralized support, each site becomes stronger and better equipped to deliver for patients and sponsors.

For example, Juno’s endocrinologists in Houston helped the Lenexa vaccine site grow into cardiometabolic research. For studies requiring specialized expertise, we’ve brought in GI and cardiology experts who serve as investigators or refer patients to our studies.

We’ve also built specialized infrastructure that provides every site with central recruitment, contracting, regulatory, and study startup support.

For sponsors, this means patient access no single site could offer alone. That helps us deliver strong enrollment performance, with one quality standard across sites.

For patients, this means more access to trials for chronic conditions like diabetes and kidney disease. And for our staff, it means the chance to work on studies beyond vaccines.

Built to keep growing

Sequoias can live for thousands of years, and mature trees keep adding wood every year. That’s the kind of network we’re building: one meant to last and to keep growing.

More physicians are looking to add research to their practices. Our shared support makes it easier for them to do that.

Growth like this builds trust with sponsors over time, study after study. It also lets us reach more communities and give people a care option they might not otherwise have.

A brighter future for clinical research

As we begin our journey as Sequoia Clinical Research, I’m excited about the future as we grow together across our sites, with our sponsors, and the communities we serve.